NCT00484328View on ClinicalTrials.gov

Ribavirin, Its Dosing Regime

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hepatitis C
Interventions
DRUG

Ribavirin

different dosing regimes of Ribavirin

Trial Locations (1)

6229 ER

University of Maastricht, Maastricht

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Maastricht University Medical Center

OTHER

NCT00484328 - Ribavirin, Its Dosing Regime | Biotech Hunter | Biotech Hunter